Teleflex Incorporated (NYSE:TFX) Shares Sold by LGT Capital Partners LTD.

LGT Capital Partners LTD. lowered its stake in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 34.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 152,657 shares of the medical technology company’s stock after selling 79,028 shares during the quarter. LGT Capital Partners LTD. owned about 0.33% of Teleflex worth $27,170,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of TFX. Janus Henderson Group PLC increased its holdings in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after acquiring an additional 147,147 shares in the last quarter. FMR LLC increased its holdings in shares of Teleflex by 70.1% during the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock valued at $66,650,000 after acquiring an additional 111,086 shares in the last quarter. Point72 Asset Management L.P. increased its holdings in shares of Teleflex by 31.2% during the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after acquiring an additional 96,958 shares in the last quarter. Parkman Healthcare Partners LLC acquired a new position in shares of Teleflex during the third quarter valued at about $23,778,000. Finally, Raymond James Financial Inc. acquired a new position in shares of Teleflex during the fourth quarter valued at about $10,342,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on TFX shares. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Piper Sandler reiterated a “neutral” rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. Morgan Stanley cut their price target on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday. Truist Financial lowered their price objective on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. Finally, Bank of America lowered Teleflex from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Teleflex presently has an average rating of “Hold” and an average price target of $182.63.

Get Our Latest Research Report on Teleflex

Teleflex Trading Up 2.9 %

Shares of TFX stock opened at $140.24 on Friday. The stock’s fifty day moving average is $171.13 and its two-hundred day moving average is $201.30. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a market capitalization of $6.50 billion, a P/E ratio of 27.88, a PEG ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.90.

Teleflex (NYSE:TFXGet Free Report) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.